5,7-dimethyl-2-(2'-chlorophenyl)-3H-pyrrolizin-3-one

ID: ALA3786125

Chembl Id: CHEMBL3786125

PubChem CID: 127031625

Max Phase: Preclinical

Molecular Formula: C15H12ClNO

Molecular Weight: 257.72

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(C)n2c1C=C(c1ccccc1Cl)C2=O

Standard InChI:  InChI=1S/C15H12ClNO/c1-9-7-10(2)17-14(9)8-12(15(17)18)11-5-3-4-6-13(11)16/h3-8H,1-2H3

Standard InChI Key:  XOAJILBURMCFIE-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3786125

    ---

Associated Targets(Human)

HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 257.72Molecular Weight (Monoisotopic): 257.0607AlogP: 3.95#Rotatable Bonds: 1
Polar Surface Area: 22.00Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.66CX LogD: 3.66
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.76Np Likeness Score: -0.84

References

1. Kirk NS, Bezos A, Willis AC, Sudta P, Suksamrarn S, Parish CR, Ranson M, Kelso MJ..  (2016)  Synthesis and preliminary evaluation of 5,7-dimethyl-2-aryl-3H-pyrrolizin-3-ones as angiogenesis inhibitors.,  26  (7): [PMID:26912111] [10.1016/j.bmcl.2016.02.033]

Source